Rashes in Pentasa - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Rashes, when it was recovered, drug effectiveness, race, and more among people who take Pentasa (mesalamine). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Pentasa?

Pentasa has active ingredients of mesalamine. It is often used in crohn's disease. eHealthMe is studying from 23,325 Pentasa users. Check the latest studies of Pentasa.

What is Rashes?

Rashes (redness) is found to be associated with 3,711 drugs and 6,212 conditions by eHealthMe. Check the latest studies of Rashes.



On May, 26, 2026

12 people who have Rashes while taking Pentasa were studied.

Could Pentasa cause Rashes?

Severity of Rashes *:

  • least: 10 %
  • moderate: 80 %
  • severe: 10 %
  • most severe: 0.0 %

When people recovered from Rashes *:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Effectiveness of Pentasa *:

  • not at all: 0.0 %
  • somewhat: 12.5 %
  • moderate: 50.0 %
  • high: 25.0 %
  • very high: 12.5 %

Race of the people *:

  • African American, Non-Hispanic: 0.0 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.0 %
  • Hispanic: 0.0 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 0.0 %
  • White, Non-Hispanic: 100 %

Time on Pentasa *:

  • < 1 month: 27.27 %
  • 1 - 6 months: 9.09 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 18.18 %
  • 2 - 5 years: 27.27 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 18.18 %

Gender of people when taking Pentasa *:

  • female: 58.33 %
  • male: 41.67 %

Age of people when taking Pentasa *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 8.33 %
  • 40-49: 25.0 %
  • 50-59: 25.0 %
  • 60+: 8.33 %

Conditions people have *:

  1. Stress And Anxiety: 1 person, 8.33%
  2. Sclerosing Cholangitis (a disease of the bile ducts that causes inflammation and subsequent obstruction of bile): 1 person, 8.33%
  3. Perioral Dermatitis (facial rash that causes bumps to develop around the mouth): 1 person, 8.33%
  4. Pain: 1 person, 8.33%
  5. Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 8.33%
  7. High Blood Cholesterol: 1 person, 8.33%
  8. General Symptom: 1 person, 8.33%
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 8.33%
  10. Croup (a loud cough that resembles the barking of a seal and difficulty breathing): 1 person, 8.33%

Other drugs people take besides Pentasa *:

  1. Vitamin D: 2 people, 16.67%
  2. Mercaptopurine: 2 people, 16.67%
  3. Levothyroxine Sodium: 1 person, 8.33%
  4. Baclofen: 1 person, 8.33%
  5. Calcium Carbonate, Famotidine And Magnesium Hydroxide: 1 person, 8.33%
  6. Celecoxib: 1 person, 8.33%
  7. Celexa: 1 person, 8.33%
  8. Cetirizine Hydrochloride: 1 person, 8.33%
  9. Corticotropin: 1 person, 8.33%
  10. Dilaudid: 1 person, 8.33%

Other side effects people have besides Rashes *:

  1. Joint Pain: 2 people, 16.67%
  2. Viral Infection: 1 person, 8.33%
  3. Muscle Contracture (a permanent shortening of a muscle): 1 person, 8.33%
  4. Muscle Aches (muscle pain): 1 person, 8.33%
  5. Itching: 1 person, 8.33%
  6. Blood In Stool: 1 person, 8.33%
  7. Abdominal Pain: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pentasa and have Rashes?

Check whether Rashes is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

How the study uses the data?

The study is based on mesalamine (the active ingredients of Pentasa). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: